Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7
Saussez, Sven ; Université de Mons > Faculté de Médecine et de Pharmacie > Anatomie humaine et Oncologie expérimentale
Cludts, Stéphanie
Capouillez, Aurélie
Mortuaire, Geoffrey
Smetana, Karel
Kaltner, Herbert
André, Sabine
Leroy, Xavier
Gabius, Hans-Joachim
Decaestecker, Christine
Language :
English
Title :
Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7
Publication date :
01 February 2009
Journal title :
International Journal of Oncology
ISSN :
1019-6439
Publisher :
Demetrios A. Spandidos Ed. & Pub., Greece
Volume :
34
Pages :
433-439
Peer reviewed :
Peer Reviewed verified by ORBi
Research unit :
M112 - Anatomie humaine et Oncologie expérimentale M122 - Biochimie métabolique et moléculaire
Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001.
Folgueras AR, Pendás AM, Sánchez LM and López-Otín C: Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424, 2004.
Noël A, Jost M and Maquoi E: Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 19: 52-60, 2008.
Miyajima Y, Nakano R and Morimatsu M: Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 104: 678-684, 1995.
Charous SJ, Stricklin GP, Nanney LB, Netterville JL and Burkey BB: Expression of matrix metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 106: 271-278, 1997.
Riedel F, Götte K, Schwalb J, Bergler W and Hörmann K: Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 17: 1099-1105, 2000.
Franchi A, Santucci M, Masini E, Sardi I, Paglierani M and Gallo O: Expression of matrix metalloproteinase-1, matrix metalloproteinase-2 and matrix metalloproteinase-9 in carcinoma of the head and neck. Cancer 95: 1902-1910, 2002.
Christopoulos TA, Papageorgakopoulou N, Theocharis DA, Aletras AJ, Tsiganos CP, Papadas TA, Mastronikolis NS, Goumas P and Vynios DH: Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma. Int J Oncol 25: 481-485, 2004.
Ruokolainen H, Pääkkö P and Turpeenniemi-Hujanen T: Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 10: 3110-3116, 2004.
Ruokolainen H, Pääkkö P and Turpeenniemi-Hujanen T: Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker. Int J Cancer 116: 422-427, 2005.
Christopoulos TA, Papageorgakopoulou N, Ravazoula P, Mastronikolis NS, Papadas TA, Theocharis DA and Vynios DH: Expression of metalloproteinases and their tissue inhibitors in squamous cell laryngeal carcinoma. Oncol Rep 18: 855-860, 2007.
Patel BP, Shah SV, Shukla SN, Shah PM and Patel PS: Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29: 564-572, 2007.
Dumas V, Kanitakis J, Charvat S, Euvrard S, Faure M and Claudy A: Expression of basement membrane antigens and matrix metalloproteinases-2 and -9 in cutaneous basal and squamous cell carcinomas. Anticancer Res 19: 2929-2938, 1999.
Tanioka Y, Yoshida T, Yagawa T, Saiki Y, Takeo S, Harada T, Okazawa T, Yanai H and Okita K: Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89: 2116-2121, 2003.
O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M and Kay E: Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathology 51: 793-804, 2007.
Decaestecker C, Camby I, Remmelink M, Nagy N, Petein M, Pasteels JL, Van Ham P, Salmon I and Kiss R: Decision tree induction: a useful tool for assisted diagnosis and prognosis in tumor pathology. Lab Invest 76: 799-808, 1997.
Gabius HJ, Siebert HC, André S, Jiménez-Barbero J and Rüdiger H: Chemical biology of the sugar code. Chembiochem 5: 740-764, 2004.
Smetana K Jr, Dvoránková B, Chovanec M, Boucek J, Klíma J, Motlík J, Lensch M, Kaltner H, André S and Gabius HJ: Nuclear presence of adhesion/growth-regulatory galectins in normal/malignant cells of squamous epithelial origin. Histochem Cell Biol 125: 171-182, 2006.
Villalobo A, Nogales-González A and Gabius HJ: A guide to signaling pathways connecting protein-glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol 18: 1-37, 2006.
Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I, Gabius HJ and Kiss R: Galectin-7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol 13: 999-1009, 2006.
Saussez S, Decaestecker C, Lorfevre F, Cucu DR, Mortuaire G, Chevalier D, Wacreniez A, Kaltner H, André S, Toubeau G, Camby I, Gabius HJ and Kiss R: High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. Int J Oncol 30: 1109-1117, 2007.
Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ and Leroy X: Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 52: 483-493, 2008.
Saussez S, Decaestecker C, Mahillon V, Cludts S, Cappouillez A, Chevalier D, Kaltner H, Andre S, Toubeau G, Leroy X and Gabius HJ: Galectin-3 upregulation during tumor progression in head and neck cancer. Laryngoscope (In press).
Kopitz J, von Reitzenstein C, André S, Kaltner H, Uhl J, Ehemann V, Cantz M and Gabius HJ: Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J Biol Chem 276: 35917-35923, 2001.
Demers M, Magnaldo T and St-Pierre Y: A novel function for galectin-7: promoting tumorigenesis by upregulating MMP-9 gene expression. Cancer Res 65: 5205-5210, 2005.
Hyams VJ, Batsakis JG and Michaels L (eds): Tumors of the upper respiratory tract and ear. In: Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington D.C, 1998.
Wittekind C, Greene FL, Hutter RRP, Kimpfinger M and Sobin LH: TNM Atlas. 5th Edition. UICC Springer, Berlin, 2004.
Monhian N, Jewett BS, Baker SR and Varani J: Matrix metalloproteinase expression in normal skin associated with basal cell carcinoma and in distal skin from the same patients. Arch Facial Plast Surg 7: 238-243, 2005.
Coussens LM, Tinkle CL, Hanahan D and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490, 2000.
Fingleton B: MMPs as therapeutic targets - still a viable option? Semin Cell Dev Biol 19: 61-68, 2008.
Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T, Talieri M: Overexpression of matrix metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer 84: 1488-1496, 2001.
Kopitz J, André S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu FT, Cantz M, Heck AJR and Gabius HJ: Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 22: 6277-6288, 2003.
Ahmad N, Gabius HJ, Kaltner H, André S, Kuwabara I, Liu FT, Oscarson S, Norberg T and Brewer CF: Thermodynamic binding studies of cell surface carbohydrate epitopes to galectins-1, -3, and -7: evidence for differential binding specificities. Can J Chem 80: 1096-1104, 2002.
André S, Kozár T, Schuberth R, Unverzagt C, Kojima S and Gabius HJ: Substitutions in the N-glycan core as regulators of biorecognition: the case of core-fucose and bisecting GlcNAc moieties. Biochemistry 46: 6984-6995, 2007.
André S, Sanchez-Ruderisch H, Nakagawa H, Buchholz M, Kopitz J, Forberich P, Kemmner W, Böck C, Deguchi K, Detjen KM, Wiedenmann B, von Knebel Doeberitz M, Gress TM, Nishimura SI, Rosewicz S and Gabius HJ: Tumor suppressor p16INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J 274: 3233-3256, 2007.
Gabius HJ (ed): The Sugar Code. Fundamentals of glycosciences. Wiley-VCH, Weinheim, 2008.
Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M and Nakamura T: Galectin-8 modulates neutrophil function via interaction with integrin αM. Glycobiology 13: 755-763, 2003.
